Avista Capital Partners has announced it has signed a definitive agreement to invest in eMolecules.
eMolecules, based in San Diego, is provider of high-value, hard-to-find chemicals and bioreagents used in early-stage drug discovery research. Founded in 2005, the company…
Avista Capital Partners has announced it has closed its fifth fund with $1.2 billion.
The fund was over-subscribed, hit its hard-cap and exceeded its target of $775 million.
Avista Capital Partners, based in New York, is a healthcare-focused private equity…
Avista Capital Partners will acquire Miraca Life Sciences from Miraca Holdings, according to a news release.
Miraca Life Sciences, based in Irving, Texas, is a national, independent anatomic pathology lab providing subspecialty anatomic pathology services in the fields…
